Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • InderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Bolag under bevakning
    • Teamet
Pressmeddelande

RaySearch Laboratories: The Australian Bragg Centre for Proton Therapy and Research selects RayCare

Raysearch Laboratories

RaySearch Laboratories AB (publ) announces that the Australian Bragg Centre for Proton Therapy and Research (ABCPTR) in Adelaide, Australia has placed an order for the oncology information system RayCare®*.

ABCPTR is Australia's first proton therapy center and the first of its kind in the southern hemisphere. It is also RaySearch's first customer in Oceania to order RayCare. Recognizing RaySearch' global market leadership in software solutions for particle therapy, ABCPTR selected the oncology information system RayCare to ensure safe and efficient workflows. At a later stage, ABCPTR plans to place an order for RaySearch's treatment planning system RayStation®*.

Michael Penniment, Associate Professor, medical director at ABCPTR, says: "This partnership with RaySearch marks a significant step in ABCPTR's mission to revolutionize cancer care in Australia. By combining our clinical insights with RaySearch's technology, we're confident that we can push the boundaries of what's possible in proton therapy."

Johan Löf, founder and CEO, RaySearch, says: "We are very pleased that ABCPTR has selected RayCare from RaySearch. By supporting yet another treatment machine, this also confirms our already strong position in the particle therapy industry."

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.